| Name | Title | Contact Details |
|---|
OncoGenex is a biopharmaceutical company committed to the development and commercialization of new therapies that address treatment resistance in cancer patients. OncoGenex has a diverse oncology pipeline, with each product candidate having a distinct mechanism of action and representing a unique opportunity for cancer drug development. OncoGenex and Teva Pharmaceutical Industries Ltd. have entered a global collaboration and licensing agreement to develop and commercialize OncoGenex' lead drug candidate, custirsen. Custirsen is currently in Phase 3 clinical development as a treatment in men with metastatic castrate-resistant prostate cancer and in patients with advanced, unresectable non-small cell lung cancer. Apatorsen is in Phase 2 clinical development and OGX-225 is currently in pre-clinical development.
Nodality is an innovative personalized medicine company focused on improving the efficiency of drug development for therapeutics as well as generating highly predictive companion diagnostics to improve patient care.
Wellington Parc Of Owensboro is a Owensboro, KY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Rogers Behavioral Health has the expertise and experience found in a stand-alone, not-for-profit behavioral health system. Our specialized programs are known for their effectiveness in treating children, teens and adults with OCD and anxiety disorders, depression and mood disorders, eating disorders, posttraumatic stress disorder and addiction. We use proven, evidence-based treatments coupled with strong patient and family education. At Rogers, we create an environment where our patients and their families know what tomorrow will bring. Life. Worth. Living.
Pacific Island Medical Inc is a Kailua, HI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.